Oscar Health is trading 4.23% down at $30.46, with no verified company-specific announcement or analyst action identified for August 25, 2026.
- The latest material catalyst was August 6 earnings, when a Q2 beat and raised outlook were reported.
- Concerns about second-half membership churn and Affordable Care Act utilization overshadowed the results.
- The broader market is modestly higher; trading-volume details were unavailable.